Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marks

Showing results (281-290 of 683) with videos related to

Pageof 69
Sort By:
Bone Marrow Transplantation|December 23, 2017
Long-term survival following post-allograft relapse of T-cell acute lymphoblastic leukaemia: a novel approach using nelarabine and donor lymphocyte infusionsK Burley, J Wolf, E Raffoux, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1985
Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumoniaR K Scribner, D F Welch, M I Marks
The Journal of Pediatrics|August 1, 1972
Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative studyM I Marks, L Chicoine, G Legere, et al.
Pediatrics|September 1, 1974
Hydrocarbon pneumonitisN R Eade, L M Taussig, M I Marks
Canadian Medical Association Journal|May 19, 1973
Treatment of streptococcal pharyngitis. I. Clinical evaluationM Rabinovitch, R MacKenzie, M Brazeau, et al.
Cancer Biology & Therapy|June 6, 2015
Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinomaEric I Marks, Matthew Brennan, Wafik S El-Deiry
Chemotherapy|January 1, 1982
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillinM M Tarpay, D F Welch, M I Marks
Pediatrics|February 1, 1985
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonatesH R Stutman, K M Parker, M I Marks
Canadian Medical Association Journal|June 20, 1970
Fatal hepatitis in siblings: isolation of coxsackievirus B5 and herpes simplex virusM I Marks, J H Joncas, S M Mauer
Canadian Medical Association Journal|May 19, 1973
Treatment of Streptococcal Pharyngitis. II. In vitro studies of antibacterial activityM I Marks, M Rabinovitch, R MacKenzie, et al.
Pageof 69

Showing results (281-290 of 683) with videos related to

Sort By:
Pageof 69
Bone Marrow Transplantation|December 23, 2017
Long-term survival following post-allograft relapse of T-cell acute lymphoblastic leukaemia: a novel approach using nelarabine and donor lymphocyte infusionsK Burley, J Wolf, E Raffoux, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1985
Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumoniaR K Scribner, D F Welch, M I Marks
The Journal of Pediatrics|August 1, 1972
Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative studyM I Marks, L Chicoine, G Legere, et al.
Pediatrics|September 1, 1974
Hydrocarbon pneumonitisN R Eade, L M Taussig, M I Marks
Canadian Medical Association Journal|May 19, 1973
Treatment of streptococcal pharyngitis. I. Clinical evaluationM Rabinovitch, R MacKenzie, M Brazeau, et al.
Cancer Biology & Therapy|June 6, 2015
Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinomaEric I Marks, Matthew Brennan, Wafik S El-Deiry
Chemotherapy|January 1, 1982
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillinM M Tarpay, D F Welch, M I Marks
Pediatrics|February 1, 1985
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonatesH R Stutman, K M Parker, M I Marks
Canadian Medical Association Journal|June 20, 1970
Fatal hepatitis in siblings: isolation of coxsackievirus B5 and herpes simplex virusM I Marks, J H Joncas, S M Mauer
Canadian Medical Association Journal|May 19, 1973
Treatment of Streptococcal Pharyngitis. II. In vitro studies of antibacterial activityM I Marks, M Rabinovitch, R MacKenzie, et al.
Pageof 69